Home » Topics » BioWorld MedTech

BioWorld MedTech
RSS

IMMUNEX MARKETING DEAL

Jan. 30, 1992

ANALYST RECOMMENDS IDEXX

Jan. 30, 1992

BAXTER PLANS BONE MARROW TRIALS

Jan. 30, 1992

ATHENA TOXIN DESIGNATED ORPHAN

Jan. 30, 1992

BUSH BUDGET'S IMPACT ON BIOTECH

Jan. 30, 1992

TSI RAISES $25 MILLION IN OFFERING

Jan. 29, 1992

SECONDARY NETS NOVA $28.5 MILLION

Jan. 29, 1992

MATRIX IPO RAKES IN $52.5 MILLION

Jan. 29, 1992

BUSH PROMISES $76 BILLION FOR TECHNOLOGY

Jan. 29, 1992

COLLAGEN SALES CONTINUE TO LAG

Jan. 29, 1992

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 2, 2026.
AND-017 increases RBC and hemoglobin in sickle cell disease
BioWorld Science
Sickle cell disease (SCD) is an inherited hemoglobinopathy caused by a mutation in the gene encoding β-globin that results in hemoglobin S polymerization, red...
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...